#$%^&*AU2015201484A120150409.pdf#####Abstract The invention belongs to the area of medicine and can be used as a therapeutic substance and as an inhibitor of the growth of He/icobacter pylori during anti-helicobacter therapy. The invention targets the development of a new therapeutic substance that does not cause adverse reactions or side effects in the liver, blood and other organs and is capable of suppressing H. Pylor/ growth and the progression of infection. Chlorophyll-carotene paste (CGNC) is used as an active ingredient of the pharmaceutical composition for anti-helicobacter therapy, Bioeffective A. It is an inhibitor of H. pylori. CGNC can be included as a therapeutic substance in anti-helicobacter therapy. The pharmaceutical composition for anti-helicobacter therapy contains a therapeutically effective amount of chlorophyll-carotene paste and pharmaceutically acceptable carriers and/or solvents. The pharmaceutical mixture is in the form of solution, suspension, capsule, or tablets. The method of conducting anti-helicobacter therapy includes administration of an effective amount of CGNC paste to patients in drug form or as part of a pharmaceutical mixture.
